Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance [Yahoo! Finance]
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: Yahoo! Finance
Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Reported revenues were $442.6 million, representing an increase of 11.5% on a reported basis and an increase of 3.5% on an organic basis compared to the fourth quarter 2023. GAAP earnings per diluted share were $0.25, compared to $0.25 in the fourth quarter 2023. Adjusted earnings per diluted share were $0.97, compared to $0.89 in the fourth quarter 2023. Full-Year 2024 Reported revenues were $1,610.5 million, representing an increase of 4.5% on a reported basis and a decrease of 1.3% on an organic basis compared to full-year 2023. GAAP earnings per diluted share were $(0.09), compared to $0.84 in 2023. Adjusted earnings per diluted share were $2.56, compared to $3.10 in 2023. 2024 Business Highlights Appointed Mojdeh Poul as President & CEO Experienced strong demand for our differentiated portfolio of leading brands Init
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? [Yahoo! Finance]Yahoo! Finance
- ATS Corp. to make normal course issuer bid [Seeking Alpha]Seeking Alpha
- Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare ConferenceGlobeNewswire
IART
Earnings
- 10/30/25 - Beat
IART
Sec Filings
- 12/12/25 - Form 8-K
- 11/6/25 - Form SCHEDULE
- 11/6/25 - Form 4
- IART's page on the SEC website